Dr. Keay and her colleagues have isolated a protein in the urine specimens of IC patients that is unique and may prevent the growth of a new, healthy bladder lining. In addition, Dr. Keay has found that an epidermal growth factor, known to be important in bladder cell regeneration and wound healing, is significantly decreased in the urine of IC patients. These findings could lead to a new test for IC as well as a possible IC treatment. Dr. Keay's research could lead to the identification of agents that will suppress the production of this APF or enhance the production of epidermal growth factor, both of which could result in the formation of a healthy bladder lining. Also included in this special supplement is a study by ICA Medical Advisory Board Member, John Warren, M.D., and his colleagues at the University of Maryland.
Preliminary results suggest a genetic susceptibility to interstitial cystitis.
It is not a medical authority nor does it claim to have medical knowledge. In all cases, the ICA recommends that you consult your own physician regarding any course of treatment or medication. The Interstitial Cystitis Association. All Rights Reserved.